收费全文 | 1276篇 |
免费 | 69篇 |
国内免费 | 56篇 |
耳鼻咽喉 | 4篇 |
儿科学 | 75篇 |
妇产科学 | 14篇 |
基础医学 | 128篇 |
口腔科学 | 21篇 |
临床医学 | 150篇 |
内科学 | 296篇 |
皮肤病学 | 53篇 |
神经病学 | 80篇 |
特种医学 | 309篇 |
外科学 | 57篇 |
综合类 | 23篇 |
预防医学 | 45篇 |
眼科学 | 6篇 |
药学 | 73篇 |
中国医学 | 3篇 |
肿瘤学 | 64篇 |
2023年 | 4篇 |
2022年 | 4篇 |
2021年 | 8篇 |
2020年 | 12篇 |
2019年 | 14篇 |
2018年 | 22篇 |
2017年 | 7篇 |
2016年 | 11篇 |
2015年 | 18篇 |
2014年 | 24篇 |
2013年 | 44篇 |
2012年 | 39篇 |
2011年 | 24篇 |
2010年 | 44篇 |
2009年 | 58篇 |
2008年 | 30篇 |
2007年 | 64篇 |
2006年 | 26篇 |
2005年 | 28篇 |
2004年 | 15篇 |
2003年 | 16篇 |
2002年 | 17篇 |
2001年 | 23篇 |
2000年 | 20篇 |
1999年 | 27篇 |
1998年 | 72篇 |
1997年 | 81篇 |
1996年 | 101篇 |
1995年 | 62篇 |
1994年 | 60篇 |
1993年 | 53篇 |
1992年 | 18篇 |
1991年 | 16篇 |
1990年 | 22篇 |
1989年 | 37篇 |
1988年 | 40篇 |
1987年 | 34篇 |
1986年 | 45篇 |
1985年 | 43篇 |
1984年 | 9篇 |
1983年 | 14篇 |
1982年 | 13篇 |
1981年 | 9篇 |
1980年 | 11篇 |
1979年 | 8篇 |
1978年 | 12篇 |
1977年 | 9篇 |
1976年 | 13篇 |
1975年 | 13篇 |
1972年 | 2篇 |
Introduction
Major blood loss can often be life-threatening and is most commonly encountered in the settings of surgery and trauma. Patients receiving anticoagulant therapy are also at increased risk of bleeding. We investigated the use of a prothrombin complex concentrate (PCC; Beriplex P/N, CSL Behring, Marburg, Germany) to treat severe bleeding in a variety of settings: cardiac surgery, warfarin therapy and other surgery.Methods
Thirty consecutive patients who had received PCC were identified from blood transfusion records. For cardiac surgery and warfarin reversal, PCC was administered in accordance with hospital protocols. PCC was administered to cardiac and other surgical patients responding poorly to recognized blood products, whereas it was administered first-line to patients with life-threatening bleeds and requiring warfarin reversal, in accordance with British Committee for Standards in Haematology guidelines. We conducted a retrospective analysis of patient records in order to ascertain PCC dose, use of other blood products and response to PCC (clotting screen results before and after PCC administration, haemostasis achievement, and survival).Results
Six patients (20%) were excluded because of inadequate documentation (n = 5) or acquired haemophilia (n = 1). Therefore, 24 patients were included in the analysis: coronary artery bypass graft (n = 5), mitral/aortic valve replacement (n = 2), other surgery (n = 9) and warfarin reversal (n = 8). Most patients (83.3%) received no more than 1500 IU of Beriplex P/N 500. Considerable reduction in administration of other blood products was seen during the 24 hours after PCC administration. Partial or complete haemostasis was achieved in 14 out of 18 cases (77.8%). In total, 12 out of 24 patients (50%) died during the study; two-thirds of the deaths were considered unrelated to bleeding. No thrombotic complications or adverse drug reactions were observed.Conclusion
This study emphasizes the value of PCC in reversing the effects of oral anticoagulant therapy in bleeding patients. It also demonstrates the potential value of PCC in controlling bleeding in patients undergoing cardiac and other surgical procedures. The use of PCC in bleeding patients without hereditary or anticoagulation-related coagulopathy is novel, and further investigation is warranted. In the future, it may be possible to use PCC as a substitute for fresh frozen plasma in this setting; adequate documentation is crucial for all blood products. 相似文献Design: A comprehensive neuropsychological test battery was administered to healthy postmenopausal women who had been treated or not treated with long-term HRT without interruption since menopause.
Setting: Women were recruited by advertisement from a university town and surrounding areas.
Patient(s): Women 60 years or older were studied who were treated (n = 16) or not treated (n = 13) with HRT.
Intervention(s): Neuropsychological testing included tests of memory, verbal fluency, executive functions, attention and concentration, and psychomotor function. Tests of intellectual function, depressive symptoms, and emotional functioning assessed general functions and comparability of the groups.
Main Outcome Measure(s): Neuropsychological testing scores were compared between groups.
Result(s): No statistically significant differences between the groups were found for general demographic, intellectual, and psychological measures. Scores from both the Weschler Memory Scale Visual Reproduction (delayed recall) and the Digit Vigilance Test (attention) showed statistically significant better performance and fewer errors in the group of women on HRT.
Conclusion(s): Long-term postmenopausal HRT is associated with higher scores in tests of nonverbal memory and attention. 相似文献